Aug 24, 2026 04:47AM

Aug 5, 2026 07:21AM

Jul 28, 2026 06:00AM

Jul 17, 2026 04:16PM

Jul 13, 2026 02:14PM

Jul 13, 2026 02:09PM

Jul 13, 2026 10:58AM Wells Fargo Upgrades Q32 Bio Inc. (QTTB) to Overweight

Jul 13, 2026 09:33AM

Jul 13, 2026 06:59AM

Jul 10, 2026 04:06PM

Jun 25, 2026 04:15PM

May 27, 2026 08:41AM

May 22, 2026 04:19AM

May 18, 2026 06:16AM Cantor Fitzgerald Starts Q32 Bio Inc. (QTTB) at Overweight

May 5, 2026 07:46AM

Mar 10, 2026 12:20PM

Mar 10, 2026 08:42AM

Feb 25, 2026 06:06AM

Dec 19, 2025 04:09PM

Dec 18, 2025 05:57AM

Dec 1, 2025 07:07AM Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12 million

Nov 13, 2025 07:42AM

Aug 6, 2025 07:59AM

Jun 25, 2025 06:59AM

May 8, 2025 04:46PM

Apr 30, 2025 07:00AM

Apr 16, 2025 07:02AM

Mar 20, 2025 04:24PM Oppenheimer Reiterates Outperform Rating on Q32 Bio Inc. (QTTB), PT $20

Mar 11, 2025 04:53PM

Feb 11, 2025 07:26AM

Feb 11, 2025 03:09AM

Feb 10, 2025 04:05PM

Dec 12, 2024 09:04AM

Dec 11, 2024 07:25AM

Dec 11, 2024 06:37AM Q32 Bio Inc. (QTTB) PT Lowered to $20 at Oppenheimer

Dec 11, 2024 06:20AM

Dec 11, 2024 05:41AM

Dec 11, 2024 02:52AM

Dec 10, 2024 04:50PM

Dec 10, 2024 04:21PM

Dec 5, 2024 04:10PM

Oct 16, 2024 06:22AM Oppenheimer Reiterates Outperform Rating on Q32 Bio Inc. (QTTB)

Sep 11, 2024 05:56AM

Aug 19, 2024 05:51AM

Aug 8, 2024 09:22AM

Jul 9, 2024 06:59AM

Jul 1, 2024 06:59AM

443,845 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All